Tzvi Palash
2012
In 2012, Tzvi Palash earned a total compensation of $669K as Chief Operating Officer at Protalix BioTherapeutics, a 3% increase compared to previous year.
Compensation breakdown
| Bonus | $35,000 |
|---|---|
| Option Awards | $152,240 |
| Salary | $216,451 |
| Stock Awards | $199,064 |
| Other | $66,274 |
| Total | $669,029 |
Palash received $216.5K in salary, accounting for 32% of the total pay in 2012.
Palash also received $35K in bonus, $152.2K in option awards, $199.1K in stock awards and $66.3K in other compensation.
Rankings
In 2012, Tzvi Palash's compensation ranked 7,732nd out of 11,487 executives tracked by ExecPay. In other words, Palash earned more than 32.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,732 out of 11,487 | 33rd |
Division Manufacturing | 2,781 out of 4,253 | 35th |
Major group Chemicals And Allied Products | 725 out of 1,198 | 40th |
Industry group Drugs | 513 out of 920 | 44th |
Industry Biological Products, Except Diagnostic Substances | 80 out of 160 | 50th |
Source: SEC filing on October 9, 2014.
Palash's colleagues
We found four more compensation records of executives who worked with Tzvi Palash at Protalix BioTherapeutics in 2012.
2012
David Aviezer
Protalix BioTherapeutics
Chief Executive Officer
2012
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2012
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2012
Yossi Maimon
Protalix BioTherapeutics